Quarterly report [Sections 13 or 15(d)]

Business Combination - Pro Forma Information (Details)

v3.25.3
Business Combination - Pro Forma Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Pharmagesic    
Business Combination    
Net loss before taxes $ (5,022,733) $ (10,185,991)